Peptron

087010.KQ

62.57 USD

2.70

+4.51%

Overview

Last close

62.57 usd

Market cap

958.92M usd

52 week high

93.86 usd

52 week low

16.05 usd

Target price

23.81 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

604.7877

Price/Book Value

14.0526

Enterprise Value

1.37B usd

EV/Revenue

639.9525

EV/EBITDA

-17.5233

Key financials

Revenue TTM

3.95M usd

Gross Profit TTM

3.04M usd

EBITDA TTM

-7.31M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

114.58M usd

Net debt

5.43M usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.